• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

cafead

Administrator
Staff member
  • cafead   Sep 26, 2023 at 10:42: AM
via Japan's Eisai (4523.T) said on Monday its Alzheimer's treatment developed with Biogen (BIIB.O), Leqembi, was approved by the country's health ministry, making it the second nation after the United States to clear its use.

article source
 

<